523 (Cefpodoxime 200 mg)

Pill imprint 523 has been identified as Cefpodoxime proxetil 200 mg.

Cefpodoxime is used in the treatment of skin infection; bladder infection; bronchitis; gonococcal infection, disseminated; otitis media (and more), and belongs to the drug class third generation cephalosporins. There is no proven risk in humans during pregnancy. Cefpodoxime 200 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for 523

Cefpodoxime proxetil 200 mg 523
Cefpodoxime proxetil
Imprint:
523
Strength:
200 mg
Color:
Red
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Third generation cephalosporins
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Northstar Rx LLC
National Drug Code (NDC):
16714-0212

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web3)